Discovery of potent inhibitors for M

Coronavirus 3C Proteases Cysteine Endopeptidases Humans Molecular Docking Simulation Naphthoquinones Protease Inhibitors / pharmacology RNA, Viral SARS-CoV-2 Viral Nonstructural Proteins COVID-19 Drug Treatment
Alkannin/shikonin Mpro enzyme SARS-COV2 molecular dynamic simulation

Journal

Natural product research
ISSN: 1478-6427
Titre abrégé: Nat Prod Res
Pays: England
ID NLM: 101167924

Informations de publication

Date de publication:
Sep 2022
Historique:
pubmed: 16 12 2021
medline: 14 9 2022
entrez: 15 12 2021
Statut: ppublish

Résumé

Novel coronavirus disease, a serious challenge for the healthcare system, has diverted all the researchers toward the exploration of potential targets, compounds or vaccines for the management of this disease. M

Identifiants

DOI: 10.1080/14786419.2021.2013212 PMID: 34906016
pubmed: 34906016
doi: 10.1080/14786419.2021.2013212
doi:

Substances chimiques

Naphthoquinones 0
Protease Inhibitors 0
RNA, Viral 0
Viral Nonstructural Proteins 0
alkannin 075CRZ9995
shikonin 3IK6592UBW
Cysteine Endopeptidases EC 3.4.22.-
Coronavirus 3C Proteases EC 3.4.22.28

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4804-4808

Auteurs

Nitish Kumar (N)

Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.
Drug and Pollution Testing Laboratory, Guru Nanak Dev University, Amritsar, Punjab, India.
ORCID: 0000-0003-1257-0054

Jatinder Vir Singh (JV)

Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.

Kavita Bhagat (K)

Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.

Harmandeep Kaur Gulati (HK)

Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.

Anchal Sharma (A)

Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.

Archana Rani (A)

Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.

Amit Duggal (A)

Drugs Control Wing, Chandigarh, India.

Puja Gulati (P)

School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, India.

Harbinder Singh (H)

Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.

Preet Mohinder Singh Bedi (PMS)

Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.
Drug and Pollution Testing Laboratory, Guru Nanak Dev University, Amritsar, Punjab, India.

Sarabjit Kaur (S)

Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Protéines virales non structurales › Protéases virales › Protéases virales 3C › Protéases 3C des coronavirus › Discovery of potent inhibitors for M
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Peptide hydrolases › Endopeptidases › Cysteine endopeptidases › Discovery of potent inhibitors for M
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Discovery of potent inhibitors for M
questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Simulation numérique › Simulation de docking moléculaire › Discovery of potent inhibitors for M
questionsmedicales.fr › Composés polycycliques › Hydrocarbures aromatiques polycycliques › Naphtalènes › Naphtoquinones › Discovery of potent inhibitors for M
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Inhibiteurs de protéases › Discovery of potent inhibitors for M
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN viral › Discovery of potent inhibitors for M
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Discovery of potent inhibitors for M
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Protéines virales non structurales › Discovery of potent inhibitors for M
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Traitements médicamenteux de la COVID-19 › Discovery of potent inhibitors for M